Source-backed public directory

Drug Discovery startups: publicly reported investors

Explore 3 Drug Discovery portfolio companies with source-backed publicly reported investor directories. Each listing is evidence-based and may not be complete.

All Drug Discovery startups · All publicly reported investors

Hologen

Multi-modal foundation models for Neurology and Healthcare

Meridian Health Ventures
venture firm
- Source: The Times
- Source: Health Industry Leaders

Biostate AI

Generative AI to predict how each living being's health changes

Accel
venture firm
- Source: GlobeNewswire
- Source: HLTH
Gaingels
venture firm
- Source: GlobeNewswire
- Source: HLTH
Mana Ventures
venture firm
- Source: GlobeNewswire
- Source: HLTH
InfoEdge Ventures
venture firm
- Source: GlobeNewswire
- Source: HLTH
Matter Venture Partners
venture firm
- Source: GlobeNewswire
- Source: HLTH
Vision Plus Capital
venture firm
- Source: GlobeNewswire
- Source: HLTH
Catapult Ventures
venture firm
- Source: GlobeNewswire
- Source: HLTH
Dario Amodei
angel investor
- Source: GlobeNewswire
- Source: Biostate AI
Mike Schnall-Levin
angel investor
- Source: GlobeNewswire
- Source: Biostate AI
Emily Leproust
angel investor
- Source: GlobeNewswire
- Source: Biostate AI
Caltech Fund
investment firm
- Source: Biostate AI

CellType

Simulates drug response in human biology using LLMs.

Y Combinator
venture firm
- Source: PR Newswire / Senhwa Biosciences
- Source: Y Combinator

Meridian Health Ventures

InfoEdge Ventures

Matter Venture Partners

Vision Plus Capital

Dario Amodei

Mike Schnall-Levin

Emily Leproust

Caltech Fund